Prentiss Christopher B 4
4 · Adamas Pharmaceuticals Inc · Filed Nov 8, 2019
Insider Transaction Report
Form 4
Prentiss Christopher B
Chief Accounting Officer
Transactions
- Award
Common Stock
2019-11-07+25,000→ 72,209 total - Award
Stock Option (Right to Buy)
2019-11-07+50,000→ 50,000 totalExercise: $4.70Exp: 2029-11-06→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 1/4th on each of 11/1/20, 11/1/21, 11/1/22 and 11/1/23, subject to Reporting Person's Continuous Service as of each such date.
- [F2]The Option shares shall vest as follows: 1/48th of the option shares shall vest on December 1, 2019 and 1/48th shall vest monthly thereafter, subject to Reporting Person's Continuous Service as of each such date.